fda_483 · inspection_citation · high

Fujifilm Diosynth Biotechnologies Texas, LLC -- FDA 483: 8 observations (2025-03-11)

Event date
2025-03-11 00:00:00Z
Observed
2026-07-12 22:32:27Z
Source ID
3011948449-2025-03-11-192222
Payload hash
c435253e8542eb7fbd5d2b29

Summary

Observation 1: Your mu lti-product manufacturing areas are not adequately controlled to prevent potential cross-contaminatio n. Specifically, a. There are no physical or procedural segregation control...

Informational only. Not legal, financial, or medical advice.